2025 third_quarter Filing
Q3Lobbying Activities (4)
Taxation/Internal Revenue Code
View allH.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes.
Medicare/Medicaid
View allImplementation of drug pricing provisions related to H.R. 5376 (P.L. 117-169), The Inflation Reduction Act. Issues related to safe mobility. Issues related to reimbursement for breakthrough devices. Issues related to payment for prescription drugs. Issues concerning drug shortages. Issues related to extension of the hospital at home program.
H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act.
Health Issues
View allMonitored issues related to pharmaceutical prices. Issues regarding the pharmaceutical supply chain. Monitored issues concerning drug shortages. Issues concerning the reauthorization of Pandemic and All-Hazards Preparedness and Response Act (PAHPA). Monitored AI issues. Monitored cybersecurity issues. Issues concerning emergency preparedness and critical medical supplies. Issues concerning regulatory reforms.
Trade (domestic/foreign)
View allIssues related to tariffs.